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When schedules of several operant trials must be successfully
completed to obtain a reward, monkeys quickly learn to adjust
their behavioral performance by using visual cues that signal how
many trials have been completed and how many remain in the
current schedule. Bilateral rhinal (perirhinal and entorhinal) cortex
ablations irreversibly prevent this learning. Here, we apply a
recombinant DNA technique to investigate the role of dopamine
D2 receptor in rhinal cortex for this type of learning. Rhinal cortex
was injected with a DNA construct that significantly decreased D2
receptor ligand binding and temporarily produced the same pro-
found learning deficit seen after ablation. However, unlike after
ablation, the D2 receptor-targeted, DNA-treated monkeys recov-
ered cue-related learning after 11–19 weeks. Injecting a DNA
construct that decreased N-methyl-D-aspartate but not D2 receptor
ligand binding did not interfere with learning associations be-
tween the cues and the schedules. A second D2 receptor-targeted
DNA treatment administered after either recovery from a first D2
receptor-targeted DNA treatment (one monkey), after N-methyl-
D-aspartate receptor-targeted DNA treatment (two monkeys), or
after a vector control treatment (one monkey) also induced a
learning deficit of similar duration. These results suggest that the
D2 receptor in primate rhinal cortex is essential for learning to
relate the visual cues to the schedules. The specificity of the
receptor manipulation reported here suggests that this approach
could be generalized in this or other brain pathways to relate
molecular mechanisms to cognitive functions.
perirhinal cortex  entorhinal cortex  antisense  dopamine 
N-methyl-D-aspartate receptor
Monkeys, as do humans, quickly learn to use visual cues toadjust their behavior based on how much work has been
completed and how much remains (the relative workload) before
reaching a goal or obtaining a reward (1–4). Because of its strong
inputs from the ventral visual pathway and projections to the
hippocampal formation (5–13), the rhinal (perirhinal and ento-
rhinal) cortex has been heavily investigated for its role in visual
recognition memory (14) and acquisition of stimulus–stimulus
associations (15–18). In addition, we became interested in its role
in reward-related learning because of its dense innervation by
dopamine-rich fibers (19–22), which presumably arise in the
substantia nigra pars compactaventral tegmental area complex
(23). Using a behavioral task, visually cued reward schedules, in
which the monkeys are required to perform multiple operant
trials to obtain a reward at the end of a schedule, we previously
demonstrated that bilateral rhinal cortex ablations prevent mon-
keys from learning to use visual cues to make the behavioral
adjustments in the schedule task (2) and that responses of single
neurons in monkey perirhinal cortex reflect a visual cue’s
relation to the progress through a schedule, i.e., relative work-
load (3). These latter two studies led us to conclude that monkey
rhinal cortex has a critical role in establishing the associations
between visual cues and this form of reward contingency.
To test our hypothesis that dopamine, here the D2 receptor,
is critical for establishing these associations, we needed a method
to manipulate dopamine receptors during the period in which
monkeys normally learn to associate visual cues with the relative
workload. Until now, pharmacological intervention has been the
main approach for connecting receptor mechanisms to behavior.
For the experiments we describe here the conventional phar-
macological approach using a receptor ligand, in this case an
antagonist, is difficult to apply. Pharmacological effects are
often relatively short-lived, with half-times of action on the order
of minutes to a few hours, whereas the learning process we are
studying requires a week or longer to observe (2). In addition,
when anatomical localization is required, as desired for our
experiments, the pharmacological agent needs to be injected
locally and the effect of the agent is generally limited to regions
within a few millimeters of the injection sites. In this study we
needed to treat the whole rhinal cortex, which is a strip of cortex
15 mm long and 7–12 mm wide, depending on the rostral-
caudal position. Covering this region adequately with a phar-
macological agent would require many injections (40; see
Supporting Text, which is published as supporting information on
the PNAS web site), and for agents having a short-lived effect the
injections would have to be repeated daily over several weeks of
behavioral testing. Although it is likely that each set of injections
would cause only a small amount of tissue damage, the cumu-
lative tissue damage over the course of several weeks might
become substantial, thereby making inferences about the cause
of any behavioral impairment more uncertain.
Given these experimental requirements, we adapted a molec-
ular approach that has been successfully used to decrease ligand
binding by the murine D2 receptor (24–26). In the mouse,
bilateral intrastriatal injections of a DNA antisense expression
construct targeting the D2 receptor were followed by changes in
D2-mediated behaviors, including catalepsy and climbing, last-
ing several weeks. D2 receptor ligand binding was altered in
parallel with the behavioral results (25, 26). The specificity and
long duration of effects observed when using this technique
suggested it might be a particularly attractive approach to apply
to learning experiments in primates.
In this study, monkey rhinal cortex was injected with DNA
antisense expression constructs designed to interfere with the
formation of functional dopamine D2 receptors andor the
N-methyl-D-aspartate (NMDA) receptors (24). We then tested
whether this treatment impaired learning to associate visual cues
with the relative workload. There are two reasons we examined
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dopamine. First, dopamine is thought to be important for
reward-related behavior (27–29), and, second, dopamine is
present in relatively large amounts in the primate rhinal cortex
(19–22). Although the D1 receptor has often been implicated in
promoting associative learning, we initially focused on the D2
receptor for two reasons. First, the D2 receptor shows a distinc-
tive distribution with increased density in the deep layers of
rhinal cortex, suggesting that this receptor subtype might have a
special role in this tissue, whereas the D1 receptor had a more
diffuse, and, at peak, less dense, distribution (20, 21). Second,
and very important for us, was that the D2 receptor-targeted
DNA treatment had a pronounced enough effect on the D2
receptors in a murine model to be followed by large effects on
motor behavior (24–26), leading us to believe that the D2-
targeting material might be effective in the monkey also. Since
our study was undertaken, new information has come to light
also showing that the D2 receptor may play an important role in
regulating associative learning (30).
The NMDA receptor was chosen as an alternative target
because it is also abundant in the rhinal cortex (31), and an
alternative, strong hypothesis suggests that NMDA receptors are
critical for some aspects of associative learning (32–34). Finally,
using two agents provided a means to assess the specificity of the
DNA treatments, in the event of a behavioral effect.
In this study injections of DNA constructs into rhinal cortex
decreased the amount of ligand binding to the targeted, i.e., D2
or NMDA, receptors. Furthermore, the D2-targeting DNA
treatment induced the same behavioral learning deficit as occurs
after bilateral rhinal cortex ablation, with the striking difference
that the monkeys recover completely several weeks after treat-
ment (11–19). In contrast, NMDA receptor-targeting DNA
treatment did not affect the learning. The most parsimonious
explanation of our results is that a dopamine-mediated mecha-
nism involving the D2 receptor is essential for learning to
associate visual cues with the relative workload.
Materials and Methods
Experimental Apparatus. Rhesus monkeys squatted in a primate
chair facing a rear projection screen (90° x 90°) located 57 cm
away. A black and white random dot background covered the
whole screen. A touch lever, mounted inside the primate chair
at waist level, was available to register the monkeys’ responses.
A spout was placed in front of the monkeys for delivering a drop
of water (0.4 ml) as a reward.
Animal Preparation. Seven monkeys were used. Before any train-
ing or behavioral testing, each monkey was given a unilateral
rhinal cortex removal. This was done to make the injection series
somewhat less technically demanding than if both hemispheres
needed treatment with DNA. As anticipated based on previous
reports in which unilateral cortical ablations were given in
monkeys before any training or testing, the monkeys with
unilateral rhinal cortex ablations learned our task at the same
rate as intact monkeys (see Supporting Text). All animal exper-
iments were carried out in accordance with National Institutes
of Health guidelines and were approved by the National Institute
of Mental Health Animal Care and Use Committee.
Behavior: Visually Cued Reward Schedules. The monkeys were
required to perform randomly mixed schedules of one, two, or
three identical operant trials to obtain a reward (refs. 1 and 2;
Fig. 1a). For each trial, when the monkey touched a lever, a visual
cue appeared indicating where the current trial was in the current
schedule. To complete the trial correctly, the monkey was
required to release the lever when a red spot that appeared in the
center of the cue changed to green. A blue spot briefly replaced
the green spot in correct trials. If the lever was released too early
or after the green light disappeared, the trial was counted as
incorrect and repeated. A drop of liquid reward was delivered
after correct completion of the last trial of a schedule (Fig. 1a;
see Supporting Text for details). The sets of cues are shown in
Fig. 1b.
Rhinal Cortical Injections. Dopamine D2- and NMDA receptor-
targeting DNAs were constructed and injected to cover the
rhinal cortex as described in Supporting Information.
Receptor Binding Autoradiography. Two experimentally naı¨ve
monkeys, each of which received DNA injections of a single type,
were used for D2 and NMDA receptor radioligand autoradiog-
raphy by using standard methods (see Supporting Text).
Data Analysis. Behavioral data were collected and analyzed from
all sessions in which the monkeys were tested on visually cued
reward schedules. Data from each week were combined for
analysis. Performance of each individual monkey was evaluated
by using the 2 test on the numbers of correct and incorrect trials.
Group analysis was tested by using repeated measures ANOVA
with percent of errors (error rate) from each monkey in each
group. For the receptor binding studies, differences in optical
density were evaluated by using a paired t test (one-tailed). All
statistics were evaluated at P  0.05 levels.
Results
By the second week after introduction of the reward schedules,
the number of errors scored by each monkey was directly related
Fig. 1. The visually cued reward schedules task. (a) Schematic diagram of a
three-trial schedule with brightness cues. On each trial, the monkey was
required to respond when a visual target changed from red to green (see
Materials and Methods for details). The monkey initiated each trial by touch-
ing a lever. A trial was scored as correct if the monkey released the lever
200–1,000 ms after the green target (visual target) appeared. If the trial was
correctly performed a blue spot (correct trial indicator) replaced the green
target. A drop of water (reward) was delivered only after the third trial in the
schedule had been correctly completed. A visual cue was assigned to each trial;
the cue indicated how many trials had been performed and how many trials
remained to be completed before a reward was delivered (relative workload).
In the example shown here, the light gray rectangle is the cue for schedule
state 13, the dark gray rectangle is the cue for state 23, and the black
rectangle is the cue for state 33, where the schedule fraction has the trial
number in the numerator and schedule length in the denominator. (b) The five
visual cue sets used in this study. The schedule states corresponding to the cues
are shown in the top row.
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to the number of trials remaining before reward delivery (Fig. 2a;
for individual data, see Fig. 4, which is published as supporting
information on the PNAS web site). The monkeys made pro-
gressively fewer errors as the number of trials remaining before
reward became smaller (i.e., on trials closer to reward), with the
fewest errors occurring in the final, rewarded trial of each
schedule. For each of the seven monkeys, the error scores were
significantly different across the three nonrewarded schedule
states, i.e., 13, 12, and 23 states (2 test, P  0.05 for each
monkey; the schedule state fractions, 13, 23, 33, 12, 22, and
11, label trial number in the numerator and schedule length in
the denominator). The error scores were statistically indistin-
guishable in all rewarded schedule states (11, 22, 33), no
matter which schedule (one, two, or three trials) was in effect (2
test, P  0.05). Finally, the error score for each of the schedule
states was significantly different among the trials within a
schedule (2 test, P 0.05). For the entire group of monkeys, the
relation between the averaged error rates and schedule states
remained the same from the second to the fourth week of testing
(interaction term of a two-way ANOVA, F10,125  0.329, P 
0.97; Fig. 2a). The patterns of learning and performance of the
seven monkeys, all of which had unilateral rhinal cortex removals
before training began, were similar to those observed in intact
monkeys (1, 2), e.g., the learning and performance were indis-
tinguishable from the initial learning scores of the five intact
monkeys in our earlier ablation study (ref. 2; interaction term of
a two-way ANOVA, F5,71  1.74, P  0.14).
As seen before (1), the error rates were greater in the 12 than
in the 23 state for all seven monkeys (one-tailed paired t test,
df 6, t 1.94, P 0.01). Thus, the error rates depend not only
on the number of trials to be completed before reward delivery,
but also on the number of trials already completed in the current
schedule, i.e., the relative workload. Overall, the patterns of
errors indicate that the monkeys used the visual cues to adjust
their behavior based on the relative workloads.
After 4 weeks of testing on the reward schedules, each monkey
received a set of injections to introduce one of the following four
agents into the rhinal cortex of the intact hemisphere: (i) DNAs
targeting dopamine D2 and NMDA receptors (n  2 monkeys);
(ii) DNA targeting only the D2 receptor (n  2); (iii) DNA
targeting the NMDA receptor (n  2); or (iv) vector only (n 
1). After the DNA injections, each monkey was tested in the
same reward schedules but was presented with a new set of cues
(length cues; Fig. 1b). By the second week, the performance of
the three monkeys receiving either the NMDA receptor-targeted
treatment or vector-only treatment was the same as before the
treatment (Fig. 2b). That is, the relationship between the error
rates and schedule states obtained with the new length cues was
statistically indistinguishable from the relationship observed
before treatment (interaction term between schedule states and
week of testing in a two-way ANOVA, F5,35  1.65, P  0.18).
The behavior was stable from the second to the fourth week
(interaction term of a two-way ANOVA, F10,53  0.287, P 
0.98). Thus, monkeys receiving treatment targeting rhinal cortex
NMDA receptors or only vector learned new cue sets at a rate
similar to that measured before the treatment, indicating that
these treatments were without effect.
In contrast, all four monkeys receiving a D2 receptor-targeted
treatment (combined DNA targeting D2 and NMDA receptors,
n  2; DNA targeting the D2 receptor alone, n  2) failed to
adjust their error rates across different schedule states for 11–19
weeks after the injections (see Supporting Text). The data
collected in the fourth week after the introduction of the length
cue (eighth week after injection) are shown in Fig. 2b (single-
factor ANOVA, F5,23 0.368, P 0.86). During the 11–19 weeks
after the injections, monkeys receiving DNA constructs target-
ing the D2 receptor showed the same deficit in associating visual
cues with reward schedules as observed in monkeys with bilateral
rhinal cortex removals (2). After regaining the ability to use the
cues, the behavior was stable; the relationships between the
Fig. 2. Error rates of monkeys performing the visually cued reward schedules in the different conditions. Each bar represents the mean error rate for that
schedule state; the error bars are SEMs. * marks the conditions in which the error rates were distinguishable (single-factor ANOVA, P 0.05) across the schedule
states, indicating that the monkeys were using the cues to adjust their behavior (see text for details). (a) Error rates of monkeys using brightness cues in the fourth
week of testing after the cue’s introduction before any treatment. (b) Error rates of different groups of monkeys using length cues in the eighth week after
delivery of DNA constructs into the rhinal cortex, i.e., the fourth week after introduction of the length cue. Groups of monkeys were injected with the following:
(i) a mixture of D2- and NMDA receptor-targeting constructs (Length Cues, D2NMDA); (ii) D2 receptor-targeting construct (Length Cues, D2), (iii) NMDA
receptor-targeting construct (Length Cues, NMDA), and (iv) vector (Length Cues, Control). Monkeys that received either the D2NMDA receptor-targeting
constructs or the D2 receptor-targeting construct were only impaired in learning associations between visual cues and the workload expected before reward.
(c) Error rates of the four monkeys that received the D2 receptor-targeting construct after behavioral recovery. Data were obtained during the first week after
performance had recovered from the effect of either the D2- and NMDA-targeting construct mixture or D2 receptor-targeting construct alone (12–20 weeks
after injection) (Length Cues, Recovered), and during the third week after new cues have been introduced to the same monkeys (Pattern Cues). (d) Error rates
of the monkeys that received the second treatment of D2 receptor-targeting construct (D2, n  3; and mixture of D2 and NMDA, n  1). Data (Pattern Cues 2,
D2) were obtained during the eighth week after treatment and show that the monkeys did not use the cues to adjust their behavior. Data (Pattern Cues 2,
Recovered) collected from the same monkeys during the 12th week after injection, which is the first week after performance had recovered from the effect of
the treatments, and during the third week after new cues have been introduced (Pattern Cues 3).
12338  www.pnas.orgcgidoi10.1073pnas.0403639101 Liu et al.
average error rates and schedule states were the same from the
first to the third week after cues were learned (interaction term
between schedule states and week of testing in a two-way
ANOVA, F10.71  0.367, P  0.96). Thus, although the effect of
this DNA treatment lasts for several weeks, it is nonetheless
temporary.
To determine whether the relearning was caused by many
weeks of practice with a specific cue set, as opposed to recovery
from treatment, the four recovered monkeys were presented
with another new cue set (pattern cues 1; Fig. 1b). After 2 weeks
of practice with the new pattern cues, the relationship between
error rates and schedule states was indistinguishable from that
observed with the initial cue set (brightness cues), before any
injections (interaction term of a two-way ANOVA, F5,47 0.736,
P 0.60; Fig. 2c). This finding, that the ability to learn new cues
recovered after treatment and proceeded at the same rate as
before DNA treatment, strongly suggests that the D2 receptor-
targeted DNA treatment had a time-limited, reversible effect on
cognitive behavior.
Finally, as a control procedure intended to determine whether
monkeys receiving D2 receptor-targeted treatment could distin-
guish among the length cues, the rectangles in the length cues
were used in place of the red and green spots in the discrimi-
nation trials. With the two rectangles having the smallest length
difference in the length cues, the monkeys performed the cue
discrimination with 90% correct responses in the first testing
session.
To demonstrate further that the DNA treatment targeting the
D2 receptor was responsible for these reversible behavioral
alterations, four of the seven previously injected monkeys (one
previously received the D2 targeting construct, two previously
received the NMDA targeting construct, and one previously
received vector alone; for more detail see Table 1, which is
published as supporting information on the PNAS web site) were
given a second injection of the combination of D2- and NMDA
receptor-targeting construct (n  1) or D2 receptor-targeting
constructs alone (n  3). All four of the monkeys showed a
prolonged period during which a new set of visual cues (pattern
cues 2; Fig. 1b) failed to guide their behavior (Fig. 2d). As before,
all four of these animals learned this cue set after a minimum of
11 weeks after the injections (Table 1). Subsequently, all four
monkeys learned a fifth cue set (pattern cues 3; Fig. 1b) during
the first week after it was introduced.
To test whether our DNA treatments actually affected the
targeted receptors, we measured receptor binding by using two
experimentally naı¨ve rhesus monkeys (see Materials and Methods
and Supporting Text). Autoradiographs of [125I]iodosulpiride
binding in a brain treated with the D2 targeting DNA showed a
significant decrease in density of ligand binding in the rhinal
cortex of the treated hemisphere compared with the untreated
(control) hemisphere (Fig. 3 a and b; D2 receptor-targeting
DNA-treated side, 57.3  3.5 nCi (nCi  nanocuries; mean 
SEM; n  36 measurements per side; control side, 73.1  5.0
nCi; paired t test, t47  3.5, P  0.0005).
Autoradiographs of the [3H]MK-801 binding in a brain treated
with NMDA receptor-targeted DNA showed a significant de-
crease in density of ligand binding in the rhinal cortex-treated
hemisphere relative to the untreated hemisphere (Fig. 3c;
NMDA receptor targeting DNA-treated side, 12.8  0.4 nCi;
control side, 14.7 0.4 nCi; paired t test, t473.1, P 0.0015).
In addition, the NMDA receptor-targeted DNA treatment did
not alter the density of D2 receptor ligand binding (Fig. 3d; D2
receptor binding of NMDA receptor-targeted, DNA-treated
side, 197.9  10.6 nCi; D2 receptor binding on control side,
200.2  10.2 nCi; paired t test, t47  0.5, P  0.299).
Discussion
We have demonstrated that treatment of the rhinal cortex with
a DNA construct designed to reduce D2 receptor function leads
to a significant, yet reversible, deficit in learning to associate
visual cues with the relative workload, i.e., number of trials that
have been completed and the number of trials remaining in the
current schedule. Strikingly, these animals exhibited recovery of
the cognitive function between 11 and 19 weeks after the
treatment, whereas in the previous study using bilateral abla-
tions, the monkeys had not recovered 32 weeks after the
ablations at which time the study was terminated. Our conclusion
that we have produced a reversible learning deficit arising from
an alteration of D2 receptor function is supported by two main
findings: (i) our treatment significantly decreased rhinal cortex
D2 receptor ligand binding, and (ii) the effect of the treatment
was temporary, yet reinstateable.
Behavioral Paradigm. The visual cues provide information about
the number of trials to be completed before reward delivery, and
in the first trial of a schedule the cue is the only source. The
pattern of errors indicates that the monkeys used the visual cues
to adjust their behavior. Although we used an operant task and
have emphasized a role for rhinal cortex in associating visual
cues with workload, it is well recognized that operant tasks often
have features in common with Pavlovian tasks, although it is not
necessarily straightforward to separate these processes (35).
Fig. 3. Receptor binding autoradiography. (a) Autoradiograph of a single
brain section from the monkey treated with DNA construct targeting the D2
receptor showing D2 receptor ligand binding with [125I]iodosulpiride. The
rhinal cortex in the left hemisphere (between the two arrows) was treated
with DNA targeting the D2 receptor. There is a significant decrease in D2
receptor ligand binding density in the rhinal cortex of the treated relative to
the untreated hemisphere. rs indicates rhinal sulcus, amts indicates anterior
middle temporal sulcus, and A marks the amygdala. (b) D2 receptor ligand
optical density in the rhinal cortex of the monkey treated with the D2-
targeting DNA construct. Shown are the means and SEMs for the average
density of D2 receptor ligand binding in the D2 receptor construct-treated
rhinal cortex (treated) and in the untreated rhinal cortex (control). The treated
side has a significantly lower density of D2 receptor ligand binding than the
untreated side. (c) NMDA receptor ligand optical density in the rhinal cortex
of the monkey treated with the NMDA-targeting DNA construct. The NMDA
receptor-targeting DNA treatment depresses MK801 binding significantly. (d)
D2 receptor ligand optical density in the rhinal cortex of the monkey treated
with the NMDA receptor-targeting DNA construct. NMDA receptor-targeting
DNA treatment did not affect the D2 receptor ligand binding (paired t test, P
0.6). This finding indicates that treatment with the DNA construct targeting
the NMDA receptor has no nonspecific effect on D2 receptor ligand binding.
* indicates a significant difference between two hemispheres (paired t test,
P  0.05).
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In the visually cued reward schedules, both the 12 and 23
conditions are one trial before the rewarded trial, yet intact
monkeys make fewer errors in the 23 schedule state, showing
that the number of trials already completed in a schedule affects
the behavioral performance (compare Fig. 3), a conditional
relation seen before (1, 2, 4). Thus, the monkey’s performance
reflects learning the relationship between the visual cues and
relative workload, as opposed to time until reward per se. How
this behavioral pattern depends on the relative interplay between
Pavlovian and operant processes remains to be worked out.
Molecular Biological Approach in Monkeys. The expense and limited
supply of monkeys makes it impractical to use large numbers of
nonhuman primates to conduct extensive cellular and molecular
biological characterizations. However, we did obtain ligand
histochemistry to evaluate the specificity of the treatments with
the constructs on the targeted receptors. The histochemistry
shows that the construct treatments significantly reduced the
density of specific ligand binding of the targeted receptors. The
decrease (20% for the D2) in receptor after DNA treatment
aimed at the D2 receptor was virtually identical to the decrease
(18% there) seen after using a similar technique in the striatum
of mice that leads to marked changes in motor behavior (25).
Thus, although the measured decrease in bound ligand might not
seem large, our study is the second circumstance in which this
degree of reduction in ligand binding seems to reflect a large
enough change in receptor binding to bring about clearly mea-
surable behavioral changes. Furthermore, treatment with the
NMDA receptor-targeted DNA lowered the NMDA, but not
D2, ligand binding. These points taken together suggest that the
decrease in the amount of functional D2 receptor was both large
enough to yield an effect and was specific. Although the amount
of both D2 and NMDA ligand binding was significantly reduced,
our autoradiography results do not permit determination of the
absolute number of functional receptors in the targeted tissue
because some unbound ligand remained. Nevertheless, it is likely
that the behavioral deficit is a consequence of decreased D2
receptor binding. As for the lack of effect of the NMDA material,
there are two possible explanations: the NMDA receptors as
altered by this material do not play a role in this behavior, or the
NMDA manipulation did not lower the receptor density suffi-
ciently to cause an observable behavioral effect in this task.
The behavior of monkeys treated with the DNA targeting the
D2 receptor was only temporarily disrupted. There are two
reasons that lead us to believe that the behavioral recovery was
caused by functional restoration of D2 receptors, rather than by
recruitment of other mechanisms or brain regions. First, after
each recovery, the monkeys learned subsequent new cue sets at
the same rates as intact monkeys. Second, in one of the monkeys
a second treatment targeting the D2 receptor in rhinal cortex
reinstated the learning deficit. These two findings taken together
strongly suggest that the rhinal cortex mediates the new learning
of a new cue set after recovery. If so, restoration of D2 receptor
function would appear to be the most parsimonious explanation
for the recovery of the cognitive abilities assessed here.
It also seems unlikely that the behavioral deficit arose as a
consequence of mechanical damage from the injections for three
reasons. First, neither the NMDA receptor-targeting DNA
treatment nor the vector-alone treatment had an effect, even
though the mechanical damage should have been comparable to
that after the D2 receptor-targeting treatment. Second, behav-
ioral recovery followed by reinstatement of the deficit and
another recovery is inconsistent with permanent effects of
mechanical damage (2). Finally, the amount of tissue damage
seen on postmortem histological examination of rhinal cortex in
our cases used for histochemistry was slight, consisting of needle
tracks with slight gliosis around those tracks.
We also considered the possibility that a perceptual deficit
interfered with the monkeys’ abilities to learn about the cues.
Three pieces of evidence argue against this idea. First, the
monkeys never displayed any difficulties in the red–green dis-
criminations. In fact, after treatment with the D2 receptor-
targeting DNA their performances actually improved, in that
they made fewer errors. Second, monkeys that were impaired in
learning the associations between cues and workload performed
well when the same cues replaced the color targets in the
within-trial discrimination. Thus, the monkeys had no difficulty
discriminating the visual cues from one another. Third, previous
studies have shown that monkeys with bilateral rhinal cortex
removals can learn visual discrimination problems at the same
rate as intact controls (36–39). Therefore, it is likely that the
deficit we observed is specific to learning the associations
between visual cues and workload, as opposed to a visual
perceptual impairment.
Although our experiments do not reveal how the D2 receptor
enables this learning, several recent studies using rodents or
rodent tissue slices have shown that the D2 receptor interferes
with depotentiation (40), might mediate long-term depression
(LTD) (41), might have a role in memory consolidation (42), and
might have a role in inducing a short-lived (lasting under 4 h) or
‘‘weak’’ form of long-term potentiation (LTP) (40). The findings
in these other studies showing that the D2 receptor has a role in
LTPLTD and memory formation in behavioral experiments
makes it of particular interest to design and carry out appropriate
physiological experiments to investigate the connection between
the D2 receptor and the type of associative learning in our study.
Finally, a recent study shows that manipulation of the D2
receptor affects activity of single neurons in prefrontal cortex
during a delayed saccade working memory task (43). Wang et al.
(43) suggest that the activity affected is related to the motor
activity related to a saccade rather than being reward related.
Given our results showing that the D2 receptor is required to
learn that cues are related to reward prediction, it would be more
consistent if this prefrontal neural activity was related to having
learned the association among the cue, the saccade, and the
reward.
Molecular Targeting of Receptors. The precise molecular mecha-
nism(s) of action of DNA antisense constructs is still unidenti-
fied, even in the mouse. Regardless, each of our eight DNA
treatments targeting the D2 receptor (D2 receptor alone: four
monkeys with a total of five treatments; D2NMDA receptors:
three monkeys with one treatment each) was followed by a
severe, yet temporary, impairment in learning associations be-
tween visual cues and workload. In contrast, DNA treatment
targeting the NMDA receptor (two monkeys with one treatment
each) or consisting of vector only (one monkey with one
treatment) had no effect on learning. This repeated effect of our
treatments with the D2-targeting construct suggests a consistent
mechanism.
The DNA constructs used in this study were designed to
specifically interfere with production of functional D2 or NMDA
receptors. One possible mechanism of action is that the receptor-
targeted antisense DNA sequence in each construct produced
nucleic acid that is complementary to and hybridizes with the
respective sequence of cellular D2 or NMDA receptor tran-
scripts. Alternatively, the construct DNA could directly bind to
cellular receptor transcripts. Either mechanism could render the
targeted transcripts unavailable for translation into normal D2
or NMDA receptor protein (25, 26) through a variety of mech-
anisms including blocking translation initiation or through the
activation of endogenous RNaseH-mediated cleavage of target
RNA (44). Our consistent results in macaque monkeys should
provide an additional incentive to further characterize the
mechanisms by which the specificity of the DNA targeting arises.
Approaches using short interfering RNA (siRNA) are also
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useful for altering gene expression, but it is not clear what the
relationship of the molecular mechanisms of the technique in
this study may be to those pathways postulated to be responsible
for the effects of siRNA.
In conventional pharmacological studies, the effects of ligands
occur because they interact and bind with a receptor. Any lack
of specificity for a receptor and the associated side effects occur
because the tertiaryquartenary structure of the ligand allows
it to bind with different receptor subtypes. In our experiments,
the specificity presumably arises because we induce decreases
in the amount of a particular receptor protein, thereby reducing
the amount of functional receptor. Because it is likely that the
mechanism of action is specifically related to some aspect of
the nucleic acid sequence, we might expect a relaxed specificity
only if the sequences encoding proteins were similar. The
NMDA and D2 sequences in our constructs are not homologous
(see Supporting Text); also, there is no significant homology
between the family of D1 and D2 receptor sequences (45), so it
seems unlikely that the D2 receptor-targeted DNA affected
functioning of the D1 receptor family (including D5). Whether
some other dopamine receptor with a sequence similar to the D2
receptor protein might play a role, e.g., the D3 or D4 receptor,
remains to be studied.
Because the application of this molecular approach has not to
our knowledge been used before in monkeys, it would be
valuable to compare the results from this recombinant DNA
targeted treatment with the results of instilling classical phar-
macological agents targeting the same receptors. The agents we
used for the ligand binding experiments, sulpride and MK801,
are examples of candidates. However, for reasons provided in the
Introduction, it is unlikely that such a series of experiments could
be successfully performed. Because of the size and configuration
of the rhinal cortex, placement of several injection cannulae
would almost certainly be required to treat the entire rhinal
cortex, again leading to concern about inducing substantial
amounts of mechanical tissue damage.
We have shown that direct injection of a DNA construct
interfering with the function of the D2 receptor in the rhinal
cortex temporarily leads to a complete inability to learn associ-
ations between visual cues and the workload remaining before
reward. Thus, it appears that dopamine D2-mediated mecha-
nisms underlie the functional role that monkey rhinal cortex
plays in learning this type of association. Future studies can
determine whether other types of cognitive behavior dependent
on the rhinal cortex likewise depend on D2-mediated mecha-
nisms and also clarify the precise molecular mechanism(s) by
which DNA constructs interfere with behavior and receptor
ligand binding. Our findings offer a strong incentive for pursuing
this recombinant DNA approach as a means to interrogate and
modulate the roles of specific components of the molecular
pathways underlying behavior.
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Training and test procedures:
Initial Training. Two weeks after the
unilateral rhinal cortex removal, the monkeys
began training on the color discrimination
trials using a 1-trial schedule (the cue was
presented). During training the monkeys
received a drop of liquid reward after each
correct response. When the monkeys were able
to perform these trials at a criterion of >90%
correct for two consecutive sessions, which
took no more than two weeks of four sessions
per week for any monkey, the task was
abruptly changed so that they had to perform
the visually cued reward schedules as
described above.
Pre-injection testing and behavior.
Monkeys were tested 4 days/week for 4
consecutive weeks on the reward schedule
task. Testing during a daily session continued
until the monkeys stopped at their own
volition, typically after completing between
600 and 1000 trials. By the second week after
introduction of the reward schedules, the
number of errors scored by each monkey was
directly related to the number of trials
remaining before reward delivery (Fig. S1)
Post-injection testing. Monkeys were
given 3 weeks to recover from the surgery in
which DNA constructs were injected. In all
cases recovery was uneventful. The
subsequent testing procedure was as follows:
monkeys were tested with the reward
schedules using a new set of cues for three
consecutive weeks, followed by one week of
cue discrimination testing in which the cues
were used in place of the red and green spots
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Figure S1. Monkeys (mk 1-7) with unilateral rhinal cortex lesions initially learned
to associate brightness cues with relative workload. Data shown here were obtained
from the 2nd week of testing after the introduction of the visually cued reward
schedules using brightness cues.  Each bar represents the mean error rate averaged
over all monkeys (n = 7) for that schedule state. Symbols show the error rates of
individual monkeys. In the 3/3 schedule state, 5 of the 7 points were very closely
packed so they are difficult to distinguish on this graph. The performance of these
monkeys with unilateral rhinal cortex lesions was indistinguishable from the
performance of intact monkeys (S2, S4-S8).
